Literature DB >> 16352421

Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement.

Takeshi Nakahara1, Yoichi Moroi, Hiroshi Uchi, Masutaka Furue.   

Abstract

Dendritic cells (DCs) are potent antigen-presenting cells that can stimulate resting T cells in the primary immune response. During the maturation process, immature DCs lose their ability to internalize antigens and they acquire the capacity to present antigens to naive T cells. Many observations have suggested that distinct DC subsets might differentially regulate Th responses. However, recent reports suggest that specific subsets of either murine or human DCs cultured in vitro with different stimuli respond with great plasticity in terms of both gene expression and cytokine secretion. Thus, the microenvironment of DCs may determine the nature of mature DCs and the subsequent immune response. The mechanism by which the character of DCs is determined is unknown. The in vitro maturation process of human monocyte-derived DCs (MoDC) can be initiated by various stimuli. Many stimuli induce phosphorylation of extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 MAPK in DCs during maturation. Such kinase-specific inhibitors help to reveal the functions of MAPKs in the maturation of human MoDCs. Recent studies suggest that three MAPK signaling pathways differentially regulate all aspects of phenotypic maturation, cytokine production, and functional maturation of MoDCs. Thus, distinct maturation of DCs may be induced by modulating the balance of phosphorylation of the three MAPKs. In this review, we summarize the role of MAPK signaling pathways in the maturation of human MoDCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352421     DOI: 10.1016/j.jdermsci.2005.11.004

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  89 in total

1.  Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.

Authors:  Martina Svedova; Jiri Masin; Radovan Fiser; Ondrej Cerny; Jakub Tomala; Marina Freudenberg; Ludmila Tuckova; Marek Kovar; Gilles Dadaglio; Irena Adkins; Peter Sebo
Journal:  Immunol Cell Biol       Date:  2015-10-06       Impact factor: 5.126

2.  Murine Sertoli cells promote the development of tolerogenic dendritic cells: a pivotal role of galectin-1.

Authors:  Jianxin Gao; Xujie Wang; Yunchuan Wang; Fu Han; Weixia Cai; Bin Zhao; Yan Li; Shichao Han; Xue Wu; Dahai Hu
Journal:  Immunology       Date:  2016-05-04       Impact factor: 7.397

3.  Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells.

Authors:  Bruno Miguel Neves; Ricardo Silvestre; Mariana Resende; Ali Ouaissi; Joana Cunha; Joana Tavares; Inês Loureiro; Nuno Santarém; Ana Marta Silva; Maria Celeste Lopes; Maria Teresa Cruz; Anabela Cordeiro da Silva
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

4.  Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

5.  IL-12 suppression, enhanced endocytosis and up-regulation of MHC-II and CD80 in dendritic cells during experimental endotoxin tolerance.

Authors:  Jing Zhang; Jie-ming Qu; Li-xian He
Journal:  Acta Pharmacol Sin       Date:  2009-04-06       Impact factor: 6.150

6.  Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages.

Authors:  Nazia Parveen; Raja Varman; Shiny Nair; Gobardhan Das; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

7.  Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.

Authors:  Chen Chen; Yan Meng; Lei Wang; Hong-Xia Wang; Cui Tian; Guo-Dong Pang; Hui-Hua Li; Jie Du
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

8.  Effect of dexmedetomidine, midazolam, and propofol on lipopolysaccharide-stimulated dendritic cells.

Authors:  Feng Guo; Ying Ding; Xue Yu; Xiujun Cai
Journal:  Exp Ther Med       Date:  2018-04-24       Impact factor: 2.447

9.  Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Authors:  Norimasa Matsushita; Hiroshi Komine; Annabelle Grolleau-Julius; Shari Pilon-Thomas; James J Mulé
Journal:  Cancer Immunol Immunother       Date:  2010-01-08       Impact factor: 6.968

10.  Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway.

Authors:  Jin Young Lee; Hyunah Kim; Mi Yeon Cha; Hong Gyu Park; Young-Jeon Kim; In Young Kim; Jung Mogg Kim
Journal:  J Mol Med (Berl)       Date:  2008-11-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.